6533b85dfe1ef96bd12be9dd

RESEARCH PRODUCT

Impaired T-cell-dependent protection againstLeishmania majorinfection in HIV-positive patients is associated with worsened disease outcome

Marcus MaurerKarsten WellerOmer Bébé NgouateuKonrad BröhlBlaise DondjiEsther Von StebutPierre KamtchouingA. Same-ekobo

subject

AdultCD4-Positive T-LymphocytesMaleT-LymphocytesT cellLeishmaniasis CutaneousHIV InfectionsDermatologyCXCR3BiochemistryLesionInterferon-gammaYoung AdultCutaneous leishmaniasismedicineHumansLeishmania majorAntigen-presenting cellMolecular BiologyLeishmania majorSkinbiologyCoinfectionFOXP3biology.organism_classificationmedicine.diseasemedicine.anatomical_structureImmunologyFemalemedicine.symptomCD8

description

Cutaneous leishmaniasis (CL) patients coinfected with HIV are known to show a more severe, prolonged course of disease; the immunological basis is not known. We now assessed clinical features, sera and skin biopsies of HIV(+) and HIV(-) patients with CL to identify drivers of increased susceptibility to Leishmania. CL lesion numbers, surface, and healing duration were significantly increased in HIV(+) as compared to HIV(-) patients (2.5, 14 and4-fold, respectively). Patients with HIV infection exhibited lower serum Leishmania-specific IgG levels and decreased IL-6 and IL-8. Most importantly, dramatically decreased numbers of CD4(+) T cells (approximately eightfold), but not CD8(+) cells, together with fewer CXCR3(+) Th1 cells, fewer Foxp3(+) effector/regulatory T cells, and reduced levels of IFN-γ expression were found in lesional skin. Our findings suggest that compromised CD4(+) T-cell responses may be responsible for worsened disease outcome leading to defects in parasite elimination in the absence of sufficient numbers of IFN-γ-producing Th1 cells.

https://doi.org/10.1111/exd.12646